Michael Silber leads our Pharmaceutical and Medical Products practice globally. Since joining McKinsey in 1991, Michael has focused on helping leading global organizations grow and improve performance, assisting with strategy, business development, M&A, and organizational issues.
Examples of Michael’s work include creating a comprehensive R&D strategy for a top-10 global pharmaceutical company; developing a business transformation strategy for a leading health services group; supporting a broad-based M&A program for a top-15 global pharmaceutical firm. Michael has also developed a holistic growth strategy for a leading global manufacturer of medical products, and evaluated growth opportunities in specialty devices.
|The Walt Disney Company
|The Wilkerson Group
|Stanford University, Graduate School of Business
||BA in studio art/architecture